[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Drugs Market Research Reports & Industry Analysis

The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.

Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.

A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.

Publications found: 8,211
Sort by:
North America: Vitamins Market US$ 1,999.00

... report on the vitamins market in North America covers the following countries: Canada, Mexico, and the United States of America. The report on the vitamins market in North America includes: Analysis and ...

January 2022 150 pages
Drug Screening Market by Product (Consumables, Urine Testing Devices, Analytical, Breathalyzer, Chromatography, Immunoassay) & Services, Sample Type (Urine, Breath), End User (Workplace, Laboratories, Criminal Justice, Hospitals) - Global Forecast to 2026 US$ 4,950.00

... at the highest CAGR during the forecast period” Drug screening market is segmented into products and services. The services segment is projected to ... of the drug screening market. It aims at estimating the market size and growth potential of this market across different segments such as product and service, ...

January 2022 215 pages
Vitamins and Supplements Markets in China US$ 4,000.00

China's demand for Vitamins and Supplements has grown at a fast pace in the past decade. In the next ... ) and/or US dollars. Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous ...

January 2022 200 pages
Anti Dermatomycosis Skin Drugs Markets in China US$ 4,000.00

China's demand for Anti Dermatomycosis Skin Drugs has grown at a fast pace in the past decade. In the next ... ) and/or US dollars. Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous ...

January 2022 221 pages
Anti Peptic Ulcer Drugs Markets in China US$ 4,000.00

China's demand for Anti Peptic Ulcer Drugs has grown at a fast pace in the past decade. In the next ... ) and/or US dollars. Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous ...

January 2022 211 pages
Sleep Disorder Treatment Drugs Markets in China US$ 4,000.00

China's demand for Sleep Disorder Treatment Drugs has grown at a fast pace in the past decade. In the next ... ) and/or US dollars. Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous ...

January 2022 227 pages
Anti Dermatomycosis Skin Drugs Industry Forecasts - China Focus US$ 1,800.00

This study focuses on China’s Anti Dermatomycosis Skin Drugs industry forecasts. In the ... and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s ... The primary and secondary research is done in China in order to access up-to-date government regulations, ...

January 2022 100 pages
Anti Peptic Ulcer Drugs Industry Forecasts - China Focus US$ 1,800.00

This study focuses on China’s Anti Peptic Ulcer Drugs industry forecasts. In the ... and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s ... The primary and secondary research is done in China in order to access up-to-date government regulations, ...

January 2022 107 pages
Sleep Disorder Treatment Drugs Industry Forecasts - China Focus US$ 1,800.00

This study focuses on China’s Sleep Disorder Treatment Drugs industry forecasts. In the ... and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s ... The primary and secondary research is done in China in order to access up-to-date government regulations, ...

January 2022 114 pages
Vitamins and Supplements Industry Forecasts - China Focus US$ 1,800.00

This study focuses on China’s Vitamins and Supplements industry forecasts. In the two past decades, ... -term forecasts through 2023 and 2028 are presented. The primary and secondary research is done in China in ... focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find ...

January 2022 91 pages
Anti Dermatomycosis Skin Drugs Companies in China US$ 1,800.00

This study focuses on China’s Anti Dermatomycosis Skin Drugs industry assessments and company profiles. In the two past decades, the industry has been ... 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our ...

January 2022 71 pages
Anti Peptic Ulcer Drugs Companies in China US$ 1,800.00

This study focuses on China’s Anti Peptic Ulcer Drugs industry assessments and company profiles. In the two past decades, the industry has been ... 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our ...

January 2022 54 pages
Sleep Disorder Treatment Drugs Companies in China US$ 1,800.00

This study focuses on China’s Sleep Disorder Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been ... 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our ...

January 2022 61 pages
Vitamins and Supplements Companies in China US$ 1,800.00

This study focuses on China’s Vitamins and Supplements industry assessments and company profiles. In the two past decades, the industry has been ... 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our ...

January 2022 60 pages
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) (Oncology) - Drugs in Development, 2021 US$ 2,500.00

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute M...

December 2021 4011 pages
Age Related Macular Degeneration (Ophthalmology) - Drugs in Development, 2021 US$ 2,500.00

Age Related Macular Degeneration (Ophthalmology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Age Related Macular Degenerati...

December 2021 1196 pages
Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic Receptor Subtype C4 or Alpha 2C Adrenoreceptor or ADRA2C) - Drugs In Development, 2021 US$ 3,500.00

Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic Receptor Subtype C4 or Alpha 2C Adrenoreceptor or ADRA2C) - Drugs In Development, 2021 SUMMARY According to the recently published report 'Alpha 2C Adr...

December 2021 55 pages
Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC 3.2.1.50) - Drugs In Development, 2021 US$ 3,500.00

Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC 3.2.1.50) - Drugs In Development, 2021 SUMMARY Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC...

December 2021 62 pages
Bile Duct Cancer (Cholangiocarcinoma) (Oncology) - Drugs in Development, 2021 US$ 2,500.00

Bile Duct Cancer (Cholangiocarcinoma) (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bile Duct Cancer (Cholangiocar...

December 2021 2359 pages
Cervical Intraepithelial Neoplasia (CIN) (Women's and Male Health) - Drugs in Development, 2021 US$ 2,000.00

Cervical Intraepithelial Neoplasia (CIN) (Women's and Male Health) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cervical Int...

December 2021 335 pages
Colon Cancer (Oncology) - Drugs in Development, 2021 US$ 2,500.00

Colon Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colon Cancer – Drugs In Development, 2021, provides an...

December 2021 1498 pages
Dengue Fever (Infectious Disease) - Drugs in Development, 2021 US$ 2,000.00

Dengue Fever (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dengue Fever – Drugs In Development, 2021, pr...

December 2021 203 pages
Eastern Equine Encephalitis (Infectious Disease) - Drugs in Development, 2021 US$ 2,000.00

Eastern Equine Encephalitis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Eastern Equine Encephalitis –...

December 2021 44 pages
Familial Amyloid Neuropathies (Metabolic Disorder) - Drugs in Development, 2021 US$ 2,000.00

Familial Amyloid Neuropathies (Metabolic Disorder) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Familial Amyloid Neuropathie...

December 2021 96 pages
Female Contraception (Women's and Male Health) - Drugs in Development, 2021 US$ 2,000.00

Female Contraception (Women's and Male Health) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Female Contraception – Drugs In...

December 2021 128 pages
Female Sexual Dysfunction (Women's and Male Health) - Drugs in Development, 2021 US$ 2,000.00

Female Sexual Dysfunction (Women's and Male Health) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Female Sexual Dysfunction –...

December 2021 90 pages
Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) (Musculoskeletal) - Drugs in Development, 2021 US$ 2,000.00

Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipe...

December 2021 88 pages
Glioblastoma Multiforme (GBM) (Oncology) - Drugs in Development, 2021 US$ 2,500.00

Glioblastoma Multiforme (GBM) (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Glioblastoma Multiforme (GBM) – Drugs...

December 2021 3486 pages
Graves' Ophthalmopathy (Ophthalmology) - Drugs in Development, 2021 US$ 2,000.00

Graves' Ophthalmopathy (Ophthalmology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Graves' Ophthalmopathy – Drugs In Develo...

December 2021 117 pages
Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections (Infectious Disease) - Drugs in Development, 2021 US$ 2,000.00

Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcar...

December 2021 45 pages
Hyperglycemia (Metabolic Disorder) - Drugs in Development, 2021 US$ 2,000.00

Hyperglycemia (Metabolic Disorder) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hyperglycemia – Drugs In Development, 2021,...

December 2021 34 pages
Hyperinsulinemia (Metabolic Disorder) - Drugs in Development, 2021 US$ 2,000.00

Hyperinsulinemia (Metabolic Disorder) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hyperinsulinemia – Drugs In Development,...

December 2021 85 pages
Hyperphosphatemia In Chronic Kidney Disease (Nutritional Disorders) - Drugs in Development, 2021 US$ 2,000.00

Hyperphosphatemia In Chronic Kidney Disease (Nutritional Disorders) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hyperphosph...

December 2021 75 pages
Influenza A Virus, H7N9 Subtype Infections (Infectious Disease) - Drugs in Development, 2021 US$ 2,000.00

Influenza A Virus, H7N9 Subtype Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Vir...

December 2021 114 pages
Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) - Drugs In Development, 2021 US$ 3,500.00

Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) - Drugs In Development, 2021 SUMMARY Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) pipeline Target constitutes close to 12 mol...

December 2021 77 pages
Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Drugs In Development, 2021 US$ 3,500.00

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Drugs In Development, 2021 SUMMARY Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma...

December 2021 90 pages
Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) - Drugs In Development, 2021 US$ 3,500.00

Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) - Drugs In Development, 2021 SUMMARY Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) – Interleukin-7 receptor is a protein...

December 2021 65 pages
Kidney Cancer (Renal Cell Cancer) (Oncology) - Drugs in Development, 2021 US$ 2,500.00

Kidney Cancer (Renal Cell Cancer) (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Kidney Cancer (Renal Cell Cancer)...

December 2021 4110 pages
Leptin Receptor (HuB219 or OB Receptor or CD295 or LEPR) - Drugs In Development, 2021 US$ 3,500.00

Leptin Receptor (HuB219 or OB Receptor or CD295 or LEPR) - Drugs In Development, 2021 SUMMARY According to the recently published report 'Leptin Receptor – Drugs In Development, 2021'; Leptin Receptor...

December 2021 58 pages
Medulloblastoma (Oncology) - Drugs in Development, 2021 US$ 2,000.00

Medulloblastoma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Medulloblastoma – Drugs In Development, 2021, provid...

December 2021 556 pages
Meningitis (Infectious Disease) - Drugs in Development, 2021 US$ 2,000.00

Meningitis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Meningitis – Drugs In Development, 2021, provid...

December 2021 89 pages
Merkel Cell Carcinoma (Oncology) - Drugs in Development, 2021 US$ 2,000.00

Merkel Cell Carcinoma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Merkel Cell Carcinoma – Drugs In Development,...

December 2021 1010 pages
Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Drugs In Development, 2021 US$ 3,500.00

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Drugs In Development, 2021 SUMMARY Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) pipeline Target constitutes close to 7 mo...

December 2021 44 pages
Middle East Respiratory Syndrome (MERS) (Infectious Disease) - Drugs in Development, 2021 US$ 2,000.00

Middle East Respiratory Syndrome (MERS) (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Middle East Respir...

December 2021 179 pages
Multiple Myeloma (Kahler Disease) (Oncology) - Drugs in Development, 2021 US$ 2,500.00

Multiple Myeloma (Kahler Disease) (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Multiple Myeloma (Kahler Disease)...

December 2021 2980 pages
Neuroendocrine Tumors (Oncology) - Drugs in Development, 2021 US$ 2,500.00

Neuroendocrine Tumors (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuroendocrine Tumors – Drugs In Development,...

December 2021 1317 pages
Ovarian Cancer (Oncology) - Drugs in Development, 2021 US$ 2,500.00

Ovarian Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer – Drugs In Development, 2021, provides...

December 2021 5066 pages
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) (Oncology) - Drugs in Development, 2021 US$ 2,000.00

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peripheral Nerve S...

December 2021 567 pages
Pituitary ACTH Hypersecretion (Cushing Disease) (Metabolic Disorder) - Drugs in Development, 2021 US$ 2,000.00

Pituitary ACTH Hypersecretion (Cushing Disease) (Metabolic Disorder) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pituitary...

December 2021 43 pages
Poliomyelitis (Infectious Disease) - Drugs in Development, 2021 US$ 2,000.00

Poliomyelitis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Poliomyelitis – Drugs In Development, 2021,...

December 2021 104 pages

Filters

Search

Publishers

1
8
1
27
4
165
2
1,975
5
174
29
4
4
22
51
6
142
38
1
17
1
15
13
10
651
36
1
373
16
586
4
1
1
2
16
1,197
6
166
4
84
31
2
36
3
5
4
118
187
13
16
4
2
7
15
110
2
10
42
15
21
4
2
17
4
2
1
11
32
7
11
4
34
118
34
2
1
19
4
7
3
324
8
1
1
23
31
4
11
6
1
515
24
2
5
28
44
290
17
17
13
5
19
2

Regions

5
6
6
4
9
12
4
11
9
11
5
8
9
5
9
8
7
682
274
161
55
51
45
45
43
41
21
18
18
17
17
16
15
15
14
14
14
14
14
14
14
14
13
13
13
13
13
13
13
13
13
13
13
13
13
12
12
12
12
12
12
11
11
11
10
10
9
8
8
7
6
6
5
4
3
192
10
8
4
4
4
4
4
3
3
3
3
3
3
1
1
183
3
11
14
11
16
9
6
16
15
7
150
247
5,146

Price

Date

Pages

Offers

1
1
514
290